Manganese
Research stageAlso known as Mn - Manganese.
Recent clinical, regulatory, research and industry developments relating to this drug.
Biological contributions to manganese oxides in rock varnish at Murujuga (Western Australia)
Human health risk from manganese in groundwater
Synergy between reactive manganese species and enzymes drives litter decomposition hotspots
Latitudinal manganese gradient dynamics associated with Earth’s major ice ages
Manganese risk in groundwater affects 200 million people, study shows
Manganese, a hidden threat to global water quality and health
Neuronal SLC39A8 deficiency impairs cerebellar development by altering manganese homeostasis.
Common and Trace Metals in Alzheimer's and Parkinson's Diseases.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Ecotoxicology and environmental safety1
- International journal of molecular sciences1
- JCI insight1
- Aring L1
- Aschner M1
- Choi EK1
- Correia AB1
- Doroszkiewicz J1
- Fang YY1
- Farhan JA1
- Ho TT1
- Dementia Disorders Centre1
- Department of Molecular Pharmacology at Albert Einstein College of Medicine1
- Medical University of Bialystok1
- School of Public Health1
- University of Bialystok1
- University of Michigan Medical School1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 3 of the same disease areas as Manganese in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature